Director, Regulatory Affairs - Small Molecule Strategy

Director, Regulatory Affairs - Small Molecule Strategy

Location: Boston, MA USA

Monte Rosa Therapeutics is seeking a highly skilled and self-motivated regulatory professional to join our team as an Associate Director of Regulatory Affairs. This role will focus on oncology, immunology, and related therapeutic areas. The successful candidate will be responsible for developing and implementing regulatory strategies to support the global development and approval of our innovative therapies.

Responsibilities:

• The Associate Director of regulatory Affairs will be responsible for the development and execution of the Regulatory strategy for assigned programs in alignment with the corporate goals.
• Oversee the preparation, submission, and maintenance of regulatory applications, including INDs, CTAs, marketing applications, Annual Reports, Orphan Drug Designation, Requests for Fast Track, and other regulatory documents.
• Lead and manage FDA and Health Authority interactions with FDA and global health authorities, including meetings, teleconferences, and written correspondence.
• Ensure compliance with global regulatory requirements and guidelines, including FDA, EMA, and other regulatory authorities.
• Represent Regulatory on cross-functional product team and provide strategic regulatory guidance and support to achieve product development objectives.
• Collaborate with internal and external stakeholders, manage and oversee third-party vendors and consultants to ensure high-quality submissions, and successful execution of regulatory strategies.
• Responsible for the maintenance of regulatory files and database, tracking regulatory commitments, and supporting the development of processes, SOPs, work instructions, and other controlled documents.
• Maintain working knowledge of laws, guidance, and requirements to assigned programs, in addition to general regulatory knowledge.
• Additional duties and responsibilities as required.

Qualifications:

• Bachelor's degree in health sciences or related field, or an advanced degree is preferred
• Minimum of 12 years of experience in global regulatory affairs within the pharmaceutical or biotechnology industry
• Hands-on experience in managing the preparation and timely submission of regulatory applications, such as US IND or CTA, is required. Regulatory expedited program submissions, CMC, and EU CTA experience is a plus
• In-depth knowledge of global regulatory requirements, guidelines, and processes for drug development and approval
• Strong computer skills, including knowledge of Excel, Word, PowerPoint, Outlook, and MS Project/Smartsheet.
• Experience with managing third-party vendors, regulatory operations, and consultants is a plus.
• Ability to build and maintain effective working relationships with internal and external stakeholders.

Interested candidates should forward CV and cover letter to careers-us@monterosatx.com

Monte Rosa Therapeutics (MRT) is a clinical-stage biotechnology company developing highly selective molecular glue degrader (MGD) medicines for patients living with serious diseases in the areas of oncology, autoimmune and inflammatory diseases, and more. MGDs are small molecule protein degraders that have the potential to treat many diseases that other modalities, including other degraders, cannot. Monte Rosa’s QuEEN™ (Quantitative and Engineered Elimination of Neosubstrates) discovery engine combines AI-guided chemistry, diverse chemical libraries, structural biology, and proteomics to identify degradable protein targets and rationally design MGDs with unprecedented selectivity. The QuEEN discovery engine enables access to a wide-ranging and differentiated target space of well-validated biology across multiple therapeutic areas. Monte Rosa has developed the industry’s leading pipeline of MGDs, which spans oncology, autoimmune and inflammatory disease and beyond, and has a strategic collaboration with Roche to discover and develop MGDs against targets in cancer and neurological diseases previously considered impossible to drug.

To learn more about MRTx, visit www.monterosatx.com